Effect of belimumab treatment on antiphospholipid antibody levels: post-hoc analysis based on two randomised placebo-controlled trials in systemic lupus erythematosus

被引：25
|
作者：
Chatzidionysiou, Katerina [1 ]
Samoli, Evangelia [2 ]
Sfikakis, Petros P. [1 ]
Tektonidou, Maria G. [1 ]
机构：
[1] Natl & Kapodistrian Univ Athens, Dept Propaedeut & Internal Med 1, Joint Rheumatol Program, Laiko Hosp,Med Sch, Athens, Greece
[2] Natl & Kapodistrian Univ Athens, Sch Med, Dept Hyg Epidemiol & Med Stat, Athens, Greece
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2020年 / 79卷 / 02期
关键词：
D O I：
10.1136/annrheumdis-2019-216367
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：304 / +
页数：4
相关论文
共 50 条
  • [31] Chinese Herbal Medicine for Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis of Randomized, Placebo-Controlled Trials
    WANG Ying
    HAN Mei
    Christopher E.Pedigo
    XIE Zhi-min
    WANG Wei-jie
    LIU Jian-ping
    Chinese Journal of Integrative Medicine, 2021, 27 (10) : 778 - 787
  • [32] Chinese Herbal Medicine for Systemic Lupus Erythematosus: A Systematic Review and Meta-analysis of Randomized, Placebo-Controlled Trials
    Ying Wang
    Mei Han
    Christopher E. Pedigo
    Zhi-min Xie
    Wei-jie Wang
    Jian-ping Liu
    Chinese Journal of Integrative Medicine, 2021, 27 : 778 - 787
  • [33] Chinese Herbal Medicine for Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis of Randomized, Placebo-Controlled Trials
    WANG Ying
    HAN Mei
    Christopher EPedigo
    XIE Zhimin
    WANG Weijie
    LIU Jianping
    Chinese Journal of Integrative Medicine , 2021, (10) : 778 - 787
  • [34] PREGNANCY OUTCOMES FOR SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) SUBJECTS WITH CONCEPTION DURING BELIMUMAB INTRAVENOUS (IV) AND SUBCUTANEOUS (SC) PLACEBO-CONTROLLED CLINICAL TRIALS AND LONG TERM EXTENSION TRIALS
    Powell, M.
    Hill, D.
    Eudy, A.
    Landy, H.
    Petri, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 75 - 76
  • [35] Effect of patient characteristics on the efficacy and safety of imeglimin monotherapy in Japanese patients with type 2 diabetes mellitus: A post-hoc analysis of two randomized, placebo-controlled trials
    Hagi, Katsuhiko
    Kochi, Kenji
    Watada, Hirotaka
    Kaku, Kohei
    Ueki, Kohjiro
    JOURNAL OF DIABETES INVESTIGATION, 2023, 14 (09) : 1101 - 1109
  • [36] PHARMACODYNAMIC EFFECT OF SEQUENTIAL BELIMUMAB (BEL) AND RITUXIMAB (RTX) THERAPY IN PATIENTS (PTS) WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): THE PHASE 3, RANDOMISED, PLACEBO-CONTROLLED BLISS-BELIEVE STUDY
    Teng, Y. K. O.
    van Maurik, A.
    Clark, K. L.
    Fox, N. L.
    Gregan, Y. I.
    Groark, J.
    Henderson, R.
    Ocran-Appiah, J.
    Roth, D.
    Shanahan, D.
    Tak, P. P.
    Aranow, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 186 - 187
  • [37] Cardiovascular safety of vardenafil in patients receiving anti hypertensive medications: A post-hoc analysis of five placebo-controlled clinical trials
    Kloner, RA
    Mohan, P
    Segerson, T
    Thibonnier, M
    Norenberg, C
    Padma-Nathan, H
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 276A - 277A
  • [38] Long-term treatment with metformin in type 2 diabetes and vitamin D levels: A post-hoc analysis of a randomized placebo-controlled trial
    Out, Mattijs
    Top, Wiebe M. C.
    Lehert, Philippe
    Schalkwijk, Casper A.
    Stehouwer, Coen D. A.
    Kooy, Adriaan
    DIABETES OBESITY & METABOLISM, 2018, 20 (08): : 1951 - 1956
  • [39] Efficacy and Safety of Lurasidone in a Younger Population With Bipolar Depression: Pooled Post-hoc Analysis of Two Placebo-controlled Studies
    Davey, Chris
    Ratheesh, Aswin
    Tocco, Michael
    Mao, Yongcai
    George, David
    Pikalov, Andrei
    Singh, Manpreet K.
    CNS SPECTRUMS, 2023, 28 (02) : 249 - 249
  • [40] Treatment Effects of Celecoxib Oral Solution in Migraine With Aura and Without Aura: Post-Hoc Analysis of Results From Two Randomized, Double-Blind Placebo-Controlled Trials
    Tepper, Stewart
    Serrano, Daniel
    Ko, Mancia
    Kunkel, Todd
    Lipton, Richard
    NEUROLOGY, 2023, 100 (17)
12345